181 related articles for article (PubMed ID: 15998926)
21. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
22. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
Cobos A; Jovell AJ; García-Altés A; García-Closas R; Serra-Majem L
Clin Ther; 1999 Nov; 21(11):1924-36. PubMed ID: 10890264
[TBL] [Abstract][Full Text] [Related]
23. Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings.
Shalev V; Goldshtein I; Halpern Y; Chodick G
Pharmacotherapy; 2014 Jan; 34(1):1-8. PubMed ID: 23836549
[TBL] [Abstract][Full Text] [Related]
24. The comparative effectiveness of rosuvastatin vs. other statins in patients with an increased risk of failure to reach NCEP ATP III goal.
Harley CR; Gandhi S; Heien H; Nelson SP
Int J Clin Pract; 2008 Jun; 62(6):889-95. PubMed ID: 18479282
[TBL] [Abstract][Full Text] [Related]
25. Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy.
Benner JS; Tierce JC; Ballantyne CM; Prasad C; Bullano MF; Willey VJ; Erbey J; Sugano DS
Pharmacoeconomics; 2004; 22 Suppl 3():13-23. PubMed ID: 15669150
[TBL] [Abstract][Full Text] [Related]
26. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
[TBL] [Abstract][Full Text] [Related]
27. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
28. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
[TBL] [Abstract][Full Text] [Related]
29. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
30. A pilot study identifying statin nonadherence with visit-to-visit variability of low-density lipoprotein cholesterol.
Mann DM; Glazer NL; Winter M; Paasche-Orlow MK; Muntner P; Shimbo D; Adams WG; Kressin NR; Zhang Y; Choi H; Cabral H
Am J Cardiol; 2013 May; 111(10):1437-42. PubMed ID: 23433758
[TBL] [Abstract][Full Text] [Related]
31. A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization.
Valuck RJ; Williams SA; MacArthur M; Saseen JJ; Nair KV; McCollum M; Ensor JE
Clin Ther; 2003 Nov; 25(11):2936-57. PubMed ID: 14693317
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a packaging approach to improve cholesterol medication adherence.
Bosworth HB; Brown JN; Danus S; Sanders LL; McCant F; Zullig LL; Olsen MK
Am J Manag Care; 2017 Sep; 23(9):e280-e286. PubMed ID: 29087166
[TBL] [Abstract][Full Text] [Related]
33. LDL cholesterol response and statin adherence among high-risk patients initiating treatment.
Vupputuri S; Joski PJ; Kilpatrick R; Woolley JM; Robinson BE; Farkouh ME; Yun H; Safford MM; Muntner P
Am J Manag Care; 2016 Mar; 22(3):e106-15. PubMed ID: 26978237
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
35. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
[TBL] [Abstract][Full Text] [Related]
36. Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.
Toth PP; Ballantyne CM; Davidson MH; Tomassini JE; Ramey DR; Neff D; Tershakovec AM; Hu XH; Tunceli K
J Clin Lipidol; 2012; 6(2):180-91. PubMed ID: 22385552
[TBL] [Abstract][Full Text] [Related]
37. Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease.
Cheng CW; Woo KS; Chan JC; Tomlinson B; You JH
Br J Clin Pharmacol; 2004 Nov; 58(5):528-35. PubMed ID: 15521901
[TBL] [Abstract][Full Text] [Related]
38. Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin.
Swindle JP; Potash J; Kulakodlu M; Kuznik A; Buikema A
Am J Geriatr Pharmacother; 2011 Dec; 9(6):471-82. PubMed ID: 22019005
[TBL] [Abstract][Full Text] [Related]
39. Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting.
Simpson RJ; Tunceli K; Ramey DR; Neff DR; Kern DM; Hsieh HM; Wertz DA; Stephenson JJ; Marrett E; Tomassini JE; Jacobson TA
J Clin Lipidol; 2013; 7(5):399-407. PubMed ID: 24079280
[TBL] [Abstract][Full Text] [Related]
40. An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health System.
Lucas JE; Bazemore TC; Alo C; Monahan PB; Voora D
PLoS One; 2017; 12(11):e0187809. PubMed ID: 29155848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
